TD Waterhouse Canada’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-41
| Closed | -$5.64K | – | 1963 |
|
|
2024
Q1 | $5.64K | Buy |
+41
| New | +$5.64K | ﹤0.01% | 1510 |
|
|
2023
Q4 | – | Sell |
-19
| Closed | -$2.12K | – | 1771 |
|
|
2023
Q3 | $2.12K | Hold |
19
| – | – | ﹤0.01% | 1492 |
|
|
2023
Q2 | $1.79K | Hold |
19
| – | – | ﹤0.01% | 1549 |
|
|
2023
Q1 | $1.92K | Hold |
19
| – | – | ﹤0.01% | 1522 |
|
|
2022
Q4 | $2.28K | Buy |
+19
| New | +$2.28K | ﹤0.01% | 1470 |
|